Heather Manna, VP, Global Regulatory Affairs, Inceptua Early Access, answers questions about Real World Data and Early Access.
Navigating the Clinical Trial Supply Route in China
Assuring Integrity from Start to Finish
Inceptua has been actively operating in China for almost 20 years and is continuing to expand capabilities throughout the APAC region. Our office in Shanghai is where our specialist China team is based, supported by our extensive teams in Europe and the US. Therefore, Inceptua is well positioned to deliver high quality products and services compliant with the ever-developing regulatory landscape in China.
In this paper we will explore all of the possible pitfalls facing sponsors in more detail and offer some strategic solutions, helping you to understand and mitigate the risks, thereby ensuring successful results in your clinical trial program.
Latest News and Insights
We asked Mark Bainbridge, Sr. Director, Inceptua Early Access, to answer 5 quick questions about the important role Early Access is playing…
As we are strengthening our offering and presence in China, we are delighted to present Ryan Zhang as Regional Director Business Development.